A Randomized Controlled Study on the Treatment of Cirrhosis Combined With Hypersplenism
The Effects of Endoscopy Combined With Partial Splenic Artery Embolization in the Treatment of Cirrhosis With Esophageal and Gastric Varices Complicated With Hyperplenism or Splenomegaly:A Randomized Controlled Study.
Sponsor: Qilu Hospital of Shandong University
Listed as NCT05055713, this NA trial focuses on Esophageal and Gastric Varices and Hypersplenism and remains ongoing. Sponsored by Qilu Hospital of Shandong University, it has been updated 6 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Oct 2023 — Jul 2024 [monthly]
Unknown Status NA
Status: Enrolling By Invitation → Unknown Status
-
Apr 2022 — Oct 2023 [monthly]
Enrolling By Invitation NA
-
Nov 2021 — Apr 2022 [monthly]
Enrolling By Invitation NA
▶ Show 1 earlier version
-
Oct 2021 — Nov 2021 [monthly]
Enrolling By Invitation NA
First recorded
Sep 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Qilu Hospital of Shandong University
For direct contact, visit the study record on ClinicalTrials.gov .